Home
About
Resources
Blog
Infographics
Social media graphics
Videos
Policy Papers
By Topic
Partner Resources
Advocacy
Federal/State Priorities
Improving Seniors’ Timely Access to Care Act
HMPF Capitol Hill Policy Forum
File a Complaint
WPSI - Well-Woman Visit
Claims Data
Events
Contact

The Headache & Migraine Policy Forum

Home
About
Resources
Blog
Infographics
Social media graphics
Videos
Policy Papers
By Topic
Partner Resources
Advocacy
Federal/State Priorities
Improving Seniors’ Timely Access to Care Act
HMPF Capitol Hill Policy Forum
File a Complaint
WPSI - Well-Woman Visit
Claims Data
Events
Contact
AfPA Digital
November 18, 2018

Which Migraine Patients Should Get CGRP Drugs?

AfPA Digital
November 18, 2018

SCOTTSDALE -- Which patients should get the new calcitonin gene-related peptide (CGRP) monoclonal antibodies for migraine prevention -- and what will payers agree to?

Read more.

Source:https://www.medpagetoday.com/meetingcoverage/ahs/76430

Newer PostThe Migraine Thief
Older PostAmplifying the Migraine Community's Voice in ICER's Value Assessment Process

Subscribe

Thank you!
Back to Top